# The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion

Study · id `cardio:ct-nct02594995` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02594995](<https://clinicaltrials.gov/study/NCT02594995>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02594995

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 311 participants.

## Technical summary

Registry record NCT02594995. Non-randomized; no masking; primary purpose basic science. Start 2015-07 (registry gives no type); primary completion 2016-09-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 311 participants (enrolled count; ClinicalTrials.gov record NCT02594995, source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT02594995, source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)
- Primary completion: 2016-09-01 (actual) (ClinicalTrials.gov record NCT02594995, source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)
- Completion: 2019-12-30 (actual) (ClinicalTrials.gov record NCT02594995, source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02594995, source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02594995-2020-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion
- Acronym: INCIMO
- Condition: Cerebrovascular Occlusion
- Condition: Collateral Blood Circulation
- Condition: Anterior Cerebral Circulation Infarction
- Intervention (Drug): NBP
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: 48a1f1b720c3f92841ac5bff75d150e317324d0f185ad6a8b5e711176f8c6329
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
